) The Flow Cytometer Laboratory Shared Resource is located in the Cancer Therapy and Research Center and is available to all interested investigators in the cancer center. The facility provides flow cytometric analyses to optimize experimental objectives of the SACI members and supports a wide range of NIH-funded research in both clinical and basic sciences. Our current instrumentation includes a Coulter EPICS ELITE flow cytometry system fitted with one water-cooled 5-Watt argon, coherent 300-S tunable wavelength (including UV) laser and one air-cooled 15 mWatt argon Coherent laser. This instrumentation is equipped with an 80486/33 computer system that not only drives system acquisition and analysis but also operates with MS-DOS software for increased computing versatility. A coulter EPICS Model 753 flow cytometer with dual coherent argon ion lasers and one Coherent tunable dye laser is also available. This instrument is equipped with a CICERO acquisition model and a P6-200 MHV processor and 3.1 Gbyte hard drive with the latest version of Cyclops software. Basic services offered to the San Antonio Cancer Institute consist of immunophenotyping (including leukemia, lymphoma, and HIV patients), DNA content and cell cycle analysis (including apoptosis analysis), and intracellular ion concentrations and membrane potential measurement. Recent instrument upgrades now allow for rapid, sterile cell sorting. Protocols currently under development include simultaneous DNA-RNA-protein content analysis, BrdU analysis of S-phase progression, and cytokine characterization for new immunophenotyping assays.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA054174-09
Application #
6203199
Study Section
Project Start
1999-08-01
Project End
2000-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Ctrc Research Foundation
Department
Type
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Yu, Xiaojie; Zhang, Yiqiang; Ma, Xiuye et al. (2018) miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer. Cancer Lett 427:85-93
Ankerst, Donna P; Goros, Martin; Tomlins, Scott A et al. (2018) Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. Eur Urol Focus :
Arora, Sukeshi Patel; Mahalingam, Devalingam (2018) Immunotherapy in colorectal cancer: for the select few or all? J Gastrointest Oncol 9:170-179
Arellano, Luisa M; Arora, Sukeshi Patel (2018) Systemic Treatment of Advanced Hepatocellular Carcinoma in Older Adults. J Nat Sci 4:
Du, Liqin; Zhao, Zhenze; Suraokar, Milind et al. (2018) LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget 9:29601-29618
Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203
Sun, Xiujie; Gupta, Kshama; Wu, Bogang et al. (2018) Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. J Biol Chem 293:2841-2849
Horning, Aaron M; Wang, Yao; Lin, Che-Kuang et al. (2018) Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response. Cancer Res 78:853-864
Gong, Siqi; Tomusange, Khamis; Kulkarni, Viraj et al. (2018) Anti-HIV IgM protects against mucosal SHIV transmission. AIDS 32:F5-F13
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21

Showing the most recent 10 out of 989 publications